Merck

Last updated January 31, 2026

124

Innovation Areas

5,362

Inventors

Collaborations

Dpp-4 inhibitor tannate complexes: MerckRecent Research Landscape

Oxidative degradation of peptidase inhibitors during storage reduces therapeutic potency and shelf-life. This chemical stabilization strategy utilizes specific antioxidant ratios to maintain molecular integrity.

What technical problems is Merck addressing in Dpp-4 inhibitor tannate complexes?

Inadequate dermal moisture retention

(3)evidences

Chemical instability of DPP-4 inhibitors leads to loss of therapeutic potency. Preventing oxidative breakdown ensures consistent bioavailability and shelf-life.